Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin
Authors:
- 1 March 2018
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 57 (9) , 1209-1215
Abstract
Background: Standard treatment of localized squamous cell carcinoma of the anus (SCCA) is radiotherapy (RT) combined with chemotherapy, that is, chemoradiation (CRT). Primary surgery has a limited role, but is a recommended treatment for small well differentiated SCCA localized in the anal margin, with re-excision or postoperative RT/CRT in case of involved surgical margins. The evidence supporting these strategies is limited. Aim: To study the recurrence patterns and survival outcomes in patients treated with surgery alone compared with surgery followed by postoperative RT/CRT. Material and methods: From a large Nordic database we identified 93 patients with stage TxT1–2N0M0 SCCA treated with surgery alone (n = 59) or surgery followed by RT/CRT (n = 34). Surgery consisted of local excision in 86 patients and abdominoperineal resection in seven patients, all of them in the surgery alone group. In 38 (41%) of the patients, the tumor was localized merely in the anal margin and in all remaining cases the anal canal was involved. Median RT dose to the tumor bed was 54 (range 46–66) Gy. Adjuvant RT to lymph nodes was given in 75% of the patients. Half of the patients received concomitant chemotherapy, usually 5-fluorouracil and mitomycin C. Results: The locoregional recurrence (LRR) rate was significantly higher after surgery alone compared to surgery followed by adjuvant RT/CRT (36% vs. 9%, p = .006). The 3-year recurrence free survival (RFS) and overall survival (OS) were significantly better in patients who received postoperative RT/CRT than in patients who did not (3-year RFS 84.2% vs. 52.7%, p < .001 and 3-year OS 87.2% vs. 70%, p = .026). Conclusions: Surgery alone of SCCA was associated with a high LRR rate and poor survival. The addition of postoperative RT/CRT lead to significantly improved locoregional control and survival.Keywords
Funding Information
- Skåne Regional Council, Sweden
This publication has 18 references indexed in Scilit:
- Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohortRadiotherapy and Oncology, 2013
- Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trialThe Lancet Oncology, 2013
- Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivorsActa Oncologica, 2012
- Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 TrialJournal of Clinical Oncology, 2012
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal CanalJAMA, 2008
- Involved-Field, Low-Dose Chemoradiotherapy for Early-Stage Anal CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Anal canal carcinoma: Early-stage tumors ≤10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Recurrent Squamous Cell Carcinoma of the Anal Canal Predictors of Initial Treatment Failure and Results of Salvage TherapyAnnals of Surgery, 1994
- Epidermoid cancer of the anal marginThe American Journal of Surgery, 1985
- Combined therapy for cancer of the anal canalDiseases of the Colon & Rectum, 1974